Pharmacological identification of inward current evoked by dopamine in rat subthalamic neurons in vitro

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

Dopaminergic mechanisms in the subthalamic nucleus (STN) are implicated in the pathophysiology of Parkinson's disease. Here, electrophysiological responses of STN neurons to dopamine (DA) were investigated by using whole-cell patch-clamp recordings in the rat brain slice preparation. Under current-clamp, DA depolarized membrane potential and increased the frequency of spontaneous action potentials of STN neurons. Under voltage-clamp, DA (3-300 μM) produced a reversible concentration-dependent inward current (IDA; 6-40 pA) with an EC50 of 13 μM. This DA-induced current had a negative slope conductance which reversed at -102 mV. It was partially reduced by barium and by superfusion with an elevated concentration of extracellular K+. Moreover, TTX and glutamate receptor antagonists (CNQX and AP5) did not significantly affect the DA responses, indicating that IDA is not dependent upon afferent synaptic activity in the STN. Quinpirole, a D2 receptor agonist, mimicked the DA action more effectively than did the D1 agonist SKF-38393. The D2 antagonist sulpiride, but not the D1 antagonist SCH-23390, blocked responses induced by DA. Intracellular application of G-protein inhibitor GDP-β-S also suppressed IDA. GTP-γ-S, added to the pipette solution, evoked a sustained inward shift in the absence of DA. These results suggest that DA increases the activity of STN neurons via activation of G-protein-coupled D2-like receptors which reduce a K+ conductance.

Original languageEnglish (US)
Pages (from-to)772-781
Number of pages10
JournalNeuropharmacology
Volume42
Issue number6
DOIs
StatePublished - 2002

Fingerprint

Subthalamic Nucleus
Dopamine
Pharmacology
Neurons
GTP-Binding Proteins
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine
Quinpirole
6-Cyano-7-nitroquinoxaline-2,3-dione
Excitatory Amino Acid Antagonists
Sulpiride
Dopaminergic Neurons
Dopamine Agonists
Barium
Guanosine Triphosphate
In Vitro Techniques
Membrane Potentials
Action Potentials
Parkinson Disease
Brain

Keywords

  • Brain slice
  • D2 receptor
  • Dopamine
  • Potassium channel
  • Subthalamic nucleus

ASJC Scopus subject areas

  • Cellular and Molecular Neuroscience
  • Drug Discovery
  • Pharmacology

Cite this

Pharmacological identification of inward current evoked by dopamine in rat subthalamic neurons in vitro. / Zhu, Zi Tao; Shen, Ke-Zhong; Johnson, Steven.

In: Neuropharmacology, Vol. 42, No. 6, 2002, p. 772-781.

Research output: Contribution to journalArticle

@article{6b3ab6362594448e965512ac594ef065,
title = "Pharmacological identification of inward current evoked by dopamine in rat subthalamic neurons in vitro",
abstract = "Dopaminergic mechanisms in the subthalamic nucleus (STN) are implicated in the pathophysiology of Parkinson's disease. Here, electrophysiological responses of STN neurons to dopamine (DA) were investigated by using whole-cell patch-clamp recordings in the rat brain slice preparation. Under current-clamp, DA depolarized membrane potential and increased the frequency of spontaneous action potentials of STN neurons. Under voltage-clamp, DA (3-300 μM) produced a reversible concentration-dependent inward current (IDA; 6-40 pA) with an EC50 of 13 μM. This DA-induced current had a negative slope conductance which reversed at -102 mV. It was partially reduced by barium and by superfusion with an elevated concentration of extracellular K+. Moreover, TTX and glutamate receptor antagonists (CNQX and AP5) did not significantly affect the DA responses, indicating that IDA is not dependent upon afferent synaptic activity in the STN. Quinpirole, a D2 receptor agonist, mimicked the DA action more effectively than did the D1 agonist SKF-38393. The D2 antagonist sulpiride, but not the D1 antagonist SCH-23390, blocked responses induced by DA. Intracellular application of G-protein inhibitor GDP-β-S also suppressed IDA. GTP-γ-S, added to the pipette solution, evoked a sustained inward shift in the absence of DA. These results suggest that DA increases the activity of STN neurons via activation of G-protein-coupled D2-like receptors which reduce a K+ conductance.",
keywords = "Brain slice, D2 receptor, Dopamine, Potassium channel, Subthalamic nucleus",
author = "Zhu, {Zi Tao} and Ke-Zhong Shen and Steven Johnson",
year = "2002",
doi = "10.1016/S0028-3908(02)00035-7",
language = "English (US)",
volume = "42",
pages = "772--781",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Pharmacological identification of inward current evoked by dopamine in rat subthalamic neurons in vitro

AU - Zhu, Zi Tao

AU - Shen, Ke-Zhong

AU - Johnson, Steven

PY - 2002

Y1 - 2002

N2 - Dopaminergic mechanisms in the subthalamic nucleus (STN) are implicated in the pathophysiology of Parkinson's disease. Here, electrophysiological responses of STN neurons to dopamine (DA) were investigated by using whole-cell patch-clamp recordings in the rat brain slice preparation. Under current-clamp, DA depolarized membrane potential and increased the frequency of spontaneous action potentials of STN neurons. Under voltage-clamp, DA (3-300 μM) produced a reversible concentration-dependent inward current (IDA; 6-40 pA) with an EC50 of 13 μM. This DA-induced current had a negative slope conductance which reversed at -102 mV. It was partially reduced by barium and by superfusion with an elevated concentration of extracellular K+. Moreover, TTX and glutamate receptor antagonists (CNQX and AP5) did not significantly affect the DA responses, indicating that IDA is not dependent upon afferent synaptic activity in the STN. Quinpirole, a D2 receptor agonist, mimicked the DA action more effectively than did the D1 agonist SKF-38393. The D2 antagonist sulpiride, but not the D1 antagonist SCH-23390, blocked responses induced by DA. Intracellular application of G-protein inhibitor GDP-β-S also suppressed IDA. GTP-γ-S, added to the pipette solution, evoked a sustained inward shift in the absence of DA. These results suggest that DA increases the activity of STN neurons via activation of G-protein-coupled D2-like receptors which reduce a K+ conductance.

AB - Dopaminergic mechanisms in the subthalamic nucleus (STN) are implicated in the pathophysiology of Parkinson's disease. Here, electrophysiological responses of STN neurons to dopamine (DA) were investigated by using whole-cell patch-clamp recordings in the rat brain slice preparation. Under current-clamp, DA depolarized membrane potential and increased the frequency of spontaneous action potentials of STN neurons. Under voltage-clamp, DA (3-300 μM) produced a reversible concentration-dependent inward current (IDA; 6-40 pA) with an EC50 of 13 μM. This DA-induced current had a negative slope conductance which reversed at -102 mV. It was partially reduced by barium and by superfusion with an elevated concentration of extracellular K+. Moreover, TTX and glutamate receptor antagonists (CNQX and AP5) did not significantly affect the DA responses, indicating that IDA is not dependent upon afferent synaptic activity in the STN. Quinpirole, a D2 receptor agonist, mimicked the DA action more effectively than did the D1 agonist SKF-38393. The D2 antagonist sulpiride, but not the D1 antagonist SCH-23390, blocked responses induced by DA. Intracellular application of G-protein inhibitor GDP-β-S also suppressed IDA. GTP-γ-S, added to the pipette solution, evoked a sustained inward shift in the absence of DA. These results suggest that DA increases the activity of STN neurons via activation of G-protein-coupled D2-like receptors which reduce a K+ conductance.

KW - Brain slice

KW - D2 receptor

KW - Dopamine

KW - Potassium channel

KW - Subthalamic nucleus

UR - http://www.scopus.com/inward/record.url?scp=0036098558&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036098558&partnerID=8YFLogxK

U2 - 10.1016/S0028-3908(02)00035-7

DO - 10.1016/S0028-3908(02)00035-7

M3 - Article

VL - 42

SP - 772

EP - 781

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

IS - 6

ER -